SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,669,386 | +77.0% | 1,392,356 | +109.5% | 0.01% | +66.7% |
| Q1 2023 | $3,769,042 | +0.7% | 664,734 | -0.6% | 0.00% | -25.0% |
| Q4 2022 | $3,743,270 | +142.6% | 668,441 | +218.0% | 0.00% | +100.0% |
| Q1 2018 | $1,543,000 | -33.1% | 210,198 | -7.6% | 0.00% | 0.0% |
| Q4 2017 | $2,308,000 | -88.2% | 227,586 | -66.1% | 0.00% | -90.5% |
| Q2 2016 | $19,482,000 | +82.8% | 670,639 | +67.1% | 0.02% | +90.9% |
| Q1 2016 | $10,657,000 | -23.9% | 401,257 | +0.6% | 0.01% | -21.4% |
| Q4 2015 | $13,999,000 | +20.6% | 398,959 | +1.9% | 0.01% | +16.7% |
| Q3 2015 | $11,610,000 | -28.3% | 391,700 | +0.4% | 0.01% | -20.0% |
| Q2 2015 | $16,185,000 | – | 390,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |